$PFE Company News Stocking stuffers 12:27 p.m. Dec. 17,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 21, 2014 at 12:57 PM

$PFE Company News

Stocking stuffers 12:27 p.m. Dec. 17, 2014 - Mark Hulbert
Boeing’s shares get lift from dividend hike, buyback 7:23 p.m. Dec. 15, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:44 p.m. Dec. 15, 2014 - Barbara Kollmeyer
Pfizer, OPKO Health partner on growth-hormone treatment 1:50 p.m. Dec. 15, 2014 - Angela Chen
Opko Health's stock soars after Pfizer development agreement 8:15 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko's stock jumps 8.8% premarket after Pfizer development agreement 8:07 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko Health, Pfizer team up to develop Opko's GHD treatment 8:06 a.m. Dec. 15, 2014 - Tomi Kilgore
Drug makers face another $65 billion patent cliff 12:41 p.m. Dec. 10, 2014 - Russ Britt
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore
Will Santa come to Broad and Wall? 1:54 p.m. Dec. 1, 2014 - The Trading Deck
Dow buy signals push index higher 11:39 a.m. Nov. 24, 2014 - The Trading Deck
Are consumers getting gouged on health care? 9:35 a.m. Nov. 22, 2014 - Russ Britt
AstraZeneca advances in London; pound rises as inflation ticks up 11:59 a.m. Nov. 18, 2014 - Carla Mozee
Zoetis unveils $500 million buyback plan 7:52 a.m. Nov. 18, 2014 - Michael Calia
AstraZeneca forecasts revenue of $45 bln by 2023 2:42 a.m. Nov. 18, 2014 - MarketWatch.com
Updates, advisories and surprises 6:01 p.m. Nov. 17, 2014 - MarketWatch
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
U.K. stocks rise on Draghi stimulus talk; AstraZeneca drops 12:04 p.m. Nov. 17, 2014 - Carla Mozee
Pfizer, Germany’s Merck strike deal to develop cancer tumor treatment 11:05 a.m. Nov. 17, 2014 - Natalia Drozdiak

Update: Ligand Wins EU Approval For Duavive 10:02 a.m. Today - Seeking Alpha
New Pfizer bid unlikely says AstraZeneca CEO 7:09 a.m. Today - Seeking Alpha
Holiday Hikes 10:33 p.m. Dec. 19, 2014 - Barrons.com
7 Stocks Providing Their Shareholders A Growing Income With Higher Cash Dividends 10:11 p.m. Dec. 19, 2014 - Seeking Alpha
FDA Approves AstraZeneca Ovarian Cancer Drug 5:12 p.m. Dec. 19, 2014 - The Wall Street Journal Interactive Edition
United Therapeutics Lung Drug Keeps Going And Going 4:20 p.m. Dec. 19, 2014 - Investors Business Daily
Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More 4:00 p.m. Dec. 19, 2014 - Seeking Alpha
Pharma Favorites to Stand the Trials of 2015 2:29 p.m. Dec. 19, 2014 - Barrons.com
Ligand earns milestone payment on EU approval of Duavive 12:48 p.m. Dec. 19, 2014 - Seeking Alpha
Update: AstraZeneca Wins EU Approval For Lynparza 1:13 a.m. Dec. 19, 2014 - Seeking Alpha
Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog 7:07 p.m. Dec. 18, 2014 - Zacks.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog 6:48 p.m. Dec. 18, 2014 - Zacks.com
Tax Inversions Wrap Up 3:01 p.m. Dec. 18, 2014 - Seeking Alpha
Pfizer Reports Statistically Significant Results for Nerve-Pain Treatment 9:13 a.m. Dec. 18, 2014 - The Wall Street Journal Interactive Edition
Positive Phase 3 results for new formulation of Pfizer pain med 8:52 a.m. Dec. 18, 2014 - Seeking Alpha
Pfizer Is A Great Income Stock On A Pullback 2:29 a.m. Dec. 18, 2014 - Seeking Alpha
Is A Dividend Cut The End Of The World? Analysis Of Dividend-Cutting Companies, Part I 6:04 p.m. Dec. 17, 2014 - Seeking Alpha
Jacobs Drives Organic Growth on Award-Winning Contract - Analyst Blog 5:50 p.m. Dec. 17, 2014 - Zacks.com
Playing the Tax ‘Audit Lottery’ 4:02 p.m. Dec. 17, 2014 - The Wall Street Journal Interactive Edition
OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog 3:10 p.m. Dec. 17, 2014 - Zacks.com

Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer 9:10 a.m. Dec. 19, 2014 - PR Newswire - PRF
Pan American Fertilizer (TSX.V: PFE, Frankfurt: 6GF) Provides an Update on its Operations and Audit Filings and Announces Transfer to NEX 12:48 p.m. Dec. 18, 2014 - ACCESSWIRE
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia 8:00 a.m. Dec. 18, 2014 - BusinessWire - BZX
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy 8:01 a.m. Dec. 17, 2014 - BusinessWire - BZX
Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts 10:00 a.m. Dec. 16, 2014 - BusinessWire - BZX
Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis 8:02 a.m. Dec. 16, 2014 - BusinessWire - BZX
Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology 6:30 p.m. Dec. 15, 2014 - BusinessWire - BZX
Pfizer Declares First-Quarter 2015 Dividend 12:06 p.m. Dec. 15, 2014 - BusinessWire - BZX
InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton 9:31 a.m. Dec. 15, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause 9:02 a.m. Dec. 10, 2014 - BusinessWire - BZX
Robbins Geller Rudman & Dowd LLP Announces Pendency of Pfizer Inc. Securities Class Action 11:00 a.m. Dec. 9, 2014 - BusinessWire - BZX
New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers 10:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc. 8:06 a.m. Dec. 8, 2014 - PR Newswire - PRF
Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform 8:02 a.m. Dec. 8, 2014 - BusinessWire - BZX
iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for Discovery and Development of Cancer Immunosuppression Targets 2:30 a.m. Dec. 8, 2014 - PR Newswire - PRF
Tenet Healthcare Names Dr. Freda C. Lewis-Hall to Board of Directors 4:00 p.m. Dec. 4, 2014 - BusinessWire - BZX
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 11:29 a.m. Dec. 4, 2014 - PR Newswire - PRF
Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative 10:00 a.m. Dec. 4, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lindian's Bold Leap into Rare Earths Processing

Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...

Baystate Noble Plans Major ED Expansion for Future Needs

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

Mammotome Ramps Up to Tackle Biopsy Needle Shortage

A Needle in High Demand There's no beating around the bush: we're staring at a breast biopsy needle shortage that's tossing the healthcare sector into a tizzy. It’s a sterner cocktail when you think that the procedure's delay isn't just a procedural hiccup. It’s a nerve-wracking limbo for patients teetering on the edge of a potential cancer diagnosis. That's where...

Qapture Expands Global DeFi Reach with Key Acquisitions

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Northern CA Super Lawyers Honor Madigan & Lewis LLP

Madigan & Lewis Surges with Prestigious Lawyer Recognitions There are firms that talk the talk, and then there's Madigan & Lewis blowing everyone off the water in Northern California's legal scene. Don't take my word for it—five of their attorneys just got the nod from Super Lawyers in a year brimming with competition. That's no small feat, and it marks them as a...

Globant Unleashes MuleSoft AI Pod for Faster Integration

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

ITP Media's Bold Move: Ready for Asian Market Surge

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

TPx Pivots Post-Bankruptcy, Rebuilding for New Growth

TPx Rebounds with Stronger Foundation Folks, TPx just got itself a fresh pair of legs to stand on. Emerging from the labyrinth of Chapter 11 bankruptcy, TPx has managed to shave off a cumbersome load of debt and cement a pathway to long-term success. A court nod from the U.S. Bankruptcy Court for the Southern District of Texas confirmed their reorganization plan. It's a...

Joseph Spine Opens New Regenerative Therapy Center

Regenerative Medicine: A New Frontier in Spine Care When spine care gets a facelift, you take notice. Joseph Spine Institute, a heavyweight in the spine care game, just threw hat into the regenerative ring. We're talking about using a patient's own cells to mend what's broken—that's advanced. They're launching a Regenerative Therapy Center in Tampa, ready to offer these...